je.st
news
Patent dispute settlement to benefit Penn cancer therapy partnership
2015-04-08 13:56:58| Biotech - Topix.net
Novartis Pharmaceutical Corp. settled its patent dispute with Juno Therapeutics, removing any potential litigation obstacles from the immunotherapy partnership between Novartis and the University of Pennsylvania. The Wall Street Journal reported Novartis will pay Seattle-based Juno $12.25 million, plus undisclosed future milestone payments and royalties, to resolve the dispute.
Tags: benefit
partnership
cancer
therapy
Category:Biotechnology and Pharmaceuticals